Hypera Pharma’s $825 Milion Acquisition Of Takeda Pharmaceutical Portfolio

Paolo Bossi

White & Case LLP and Lobo de Rizzo advised Takeda Pharmaceutical Company Limited one the deal. Cescon, Barrieu, Flesch & Barreto advised Hypera Pharma. Takeda Pharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now